Receptos reports plans to price initial public offering of its stock

Credit Suisse, Leerink Swann, BMO Capital and Wedbush assist

By Devika Patel

Knoxville, Tenn., April 4 - Receptos, Inc. intends to price an initial public offering of its common stock, according to an S-1 filed Thursday with the Securities and Exchange Commission. The company expects its shares will trade on the Nasdaq exchange under the symbol "RCPT."

The deal has a greenshoe option.

Credit Suisse Securities (USA) LLC, Leerink Swann LLC, BMO Capital Markets Corp. and Wedbush Securities Inc. are the underwriters.

Proceeds will be used for clinical studies, in-house research activities, working capital and general corporate purposes.

The biopharmaceutical company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.